[1]王黎伟,王志芬.超声引导下射频消融术与激光消融术治疗小肝癌疗效比较[J].新乡医学院学报,2022,39(4):337-340.[doi:10.7683/xxyxyxb.2022.04.007]
　WANG Liwei,WANG Zhifen.Comparison of effect between ultrasound-guided radiofrequency ablation and laser ablation in the treatment of small liver carcinoma[J].Journal of Xinxiang Medical University,2022,39(4):337-340.[doi:10.7683/xxyxyxb.2022.04.007]
点击复制

超声引导下射频消融术与激光消融术治疗小肝癌疗效比较
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
39
期数:
2022年4
页码:
337-340
栏目:
临床研究
出版日期:
2022-04-05

文章信息/Info

Title:
Comparison of effect between ultrasound-guided radiofrequency ablation and laser ablation in the treatment of small liver carcinoma
作者:
王黎伟1; 王志芬2
（1.新乡医学院第一附属医院超声科，河南　卫辉　453100；2.新乡医学院第一附属医院PICC门诊，河南　卫辉　453100）
Author(s):
WANG Liwei1; WANG Zhifen2
(1.Department of Ultrasound,the First Affiliated Hospital of Xinxiang Medical University,Weihui 453100,Henan Province,China;2.Department of PICC Clinic,the First Affiliated Hospital of Xinxiang Medical University,Weihui 453100,Henan Province,China)
关键词:
肝癌; 射频消融术; 激光消融术; 超声引导
Keywords:
liver cancer; radiofrequency ablation; laser ablation; ultrasonic guidance
分类号:
R735.7
DOI:
10.7683/xxyxyxb.2022.04.007
文献标志码:
A
摘要:
目的　比较超声引导下射频消融术（RFA）与激光消融术（LA）治疗小肝癌的临床效果。方法　选择2017年6月至2019年6月新乡医学院第一附属医院收治的146例小肝癌患者为研究对象，根据治疗方法将患者分为RFA组和LA组，每组73例。RFA组患者给予超声引导下RFA治疗，LA组患者给予超声引导下LA治疗。记录2组患者手术时间和病灶范围（即可手术病灶的直径）；分别于术后1、3、12个月进行二维超声及超声造影检查观察患者的病灶大小及动态增强情况，参照修订版实体瘤疗效评价标准评定患者临床疗效。结果　RFA组和LA组患者的手术时间分别为（25.95±1.88）、（15.62±0.88）min，LA组患者手术时间显著短于RFA组（t=43.082，P<0.05）。RFA组和LA组患者的病灶范围分别为（16.47±1.87）、（16.38±2.46）mm，2组患者病灶范围比较差异无统计学意义（t=0.390，P>0.05）。术后1、3个月及1 a，RFA组患者的肿瘤完全消除率分别为98.84%（85/86）、76.74%（66/86）、74.42%（64/86），肿瘤部分消除率分别为1.16%（1/86）、23.26%（20/86）、25.58%（22/86）；LA组患者的肿瘤完全消除率分别为97.70%（85/87）、91.95%（80/87）、89.66%（78/87），肿瘤部分消除率分别为2.30%（2/87）、8.05%（7/87）、10.34%（9/87）；术后1个月2组患者的肿瘤消除情况比较差异无统计学意义（χ2=0.330，P>0.05）；术后3个月及术后1 a，LA组患者的肿瘤消除情况显著优于RFA组（χ2=7.601、6.826，P<0.05）。2组患者腹腔出血、腹水发生率比较差异无统计学意义（χ2=0.118、0.207，P>0.05）；LA组患者恶心呕吐、发热、腹泻、气胸的发生率显著低于RFA组（χ2=32.257、22.649、3.865、5.177，P<0.05）。2组患者的并发症经临床对症治疗后均完全治愈。结论　与RFA比较，LA治疗小肝癌具有手术时间短、肿瘤消除率高及并发症发生率低等优势。
Abstract:
Objective　To compare the clinical effect of ultrasound-guided radiofrequency ablation (RFA) and laser ablation (LA) in the treatment of small liver carcinoma.Methods　A total of 146 patients with small liver carcinoma admitted to the First Affiliated Hospital of Xinxiang Medical University from June 2017 to June 2019 were selected as the research subjects,and the patients were divided into RFA group and LA group according to the treatment methods,with 73 cases in each group.The patients in the RFA group were treated with ultrasound-guided RFA,and the patients in the LA group were treated with ultrasound-guided LA.The operation time and lesion range (the diameter of operable lesions) of patients in the two groups were recorded.At 1,3 and 12 months after operation,the size and dynamic enhancement of lesions were observed by two-dimensional ultrasound and contrast-enhanced ultrasound,and the clinical effect was evaluated according to the revised response evaluation criteria in solid tumors.Results　The operation time of patients in the RFA group and LA group was (25.95±1.88) and (15.62±0.88) min,respectively.The operation time of patients in the LA group was significantly shorter than that in the RFA group (t=43.082,P<0.05).The lesion range of patients in the RFA group and the LA group was (16.47±1.87) and (16.38±2.46) mm,respectively.There was no significant difference in the lesion size of patients between the two groups (t=0.390,P>0.05).At 1,3 months and 1 year after operation,the complete tumor elimination rate of patients in the RFA group was 98.84% (85/86),76.74% (66/86) and 74.42% (64/86),respectively;and the partial tumor elimination rate was 1.16% (1/86),23.26% (20/86) and 25.58% (22/86),respectively.The tumor complete elimination rate of patients in the LA group was 97.70% (85/87),91.95% (80/87) and 89.66% (78/87),respectively;and the partial tumor elimination rate was 2.30% (2/87),8.05%(7/87) and 10.34% (9/87),respectively.There was no significant difference in tumor elimination between the two groups at one month after surgery (χ2=0.330,P>0.05).The tumor elimination of patients in the LA group was significantly better than that in the RFA group at three months and one year after operation (χ2=7.601,6.826;P<0.05).There was no significant difference in the incidence of intraabdominal hemorrhage and ascites of patients between the two groups (χ2=0.118,0.207;P>0.05).The incidences of nausea,vomiting,fever,diarrhea and pneumothorax of patients in the LA group were significantly lower than those in the RFA group (χ2=32.257,22.649,3.865,5.177;P<0.05).The complications of patients in both groups were completely cured after clinical symptomatic treatment.Conclusion　Compared with the RFA,the LA in the treatment of small liver carcinoma has the advantages of shorter operation time,higher tumor elimination rate and lower complication rate.

参考文献/References:

［1］　BERTUCCIO P,TURATI F,CARIOLI G,et al.Global trends and predictions in hepatocellular carcinoma mortality［J］.J Hepatol,2017,67(2):302-309.
［2］　SIEGEL R L,MILLER K D,JEMAL A.Cancer statistics,2019［J］.CA Cancer J Clin,2019,69(1):7-34.
［3］　XIA Y,LI J,LIU G H,et al.Long-term effects of repeat hepatectomy vs percutaneous radiofrequency ablation among patients with recurrent hepatocellular carcinoma:a randomized clinical trial［J］.JAMA Oncol,2020,6(2):255-263.
［4］　TIAN G,YANG S,YUAN J,et al.Comparative efficacy of treatment strategies for hepatocellular carcinoma:Systematic review and network meta-analysis［J］.BMJ Open,2018,8(10):e021269.
［5］　HOCQUELET A,BALAGEAS P,LAURENT C,et al.Radiofrequency ablation versus surgical resection for hepatocellular carcinoma within the Milan criteria:a study of 281 Western patients［J］.Int J Hyperthermia,2015,31(7):749-757.
［6］　HARTKE J,JOHNSON M,GHABRIL M.The diagnosis and treatment of hepatocellular carcinoma［J］.Semin Diagn Pathol,2017,34(2):153-159.
［7］　JI R,NG K K,CHEN W,et al.Comparison of clinical outcome between stereotactic body radiotherapy and radiofrequency ablation for unresectable hepatocellular carcinoma［J］.Medicine (Baltimore),2022,101(4):e28545.
［8］　KORGANBAYEV S,ORRICO A,BIANCHI L,et al.Closed-loop temperature control based on fiber bragg grating sensors for laser ablation of hepatic tissue［J］.Sensors (Basel),2020,20(22):6496.
［9］　MULIER S,MULIER P,NI Y,et al.Complications of radiofrequency coagulation of liver tumours［J］.Br J Surg,2002,89(10):1206-1222.
［10］　LlOVET J M,LENCIONI R.mRECIST for HCC:performance and novel refinements ［J］.J Hepatol,2020,72(2):288-306.
［11］　HSIAO C Y,HU R H,HO C M,et al.Surgical resection versus radiofrequency ablation for Barcelona clinic liver cancer very early stage hepatocellular carcinoma:long-term results of a single-center study［J］.Am J Surg,2020,220(4):958-964.
［12］　HEIMBACH J K,KULIK L M,FINN R S,et al.AASLD guidelines for the treatment of hepatocellular carcinoma［J］.Hepatology,2018,67(1):358-380.
［13］　SCHULLIAN P,JOHNSTON E W,PUTZER D,et al.Safety and efficacy of stereotactic radiofrequency ablation for very large (≥8 cm) primary and metastatic liver tumors［J］.Sci Rep,2020,10(1):1618.
［14］　潘东英.超声引导下激光与射频消融治疗小肝癌疗效的对比研究［D］.南京：东南大学,2017.
PAN D Y.Comparative study on the efficacy of ultrasound-guided laser and radiofrequency ablation in the treatment of small hepatocellular carcinoma［D］.Nanjing:Southeast University,2017.
［15］　LIVRAGHI T，SOLBIATI L，MELONI M F,et al.Treatment of focal liver tumors with percutaneous radio-fbquency ablation:complications encountered in a muIticenfer study［J］.Radiology,2003,226(2):441-451.
［16］　金鹏，孙钢.肝癌消融治疗的研究进展［J］.中华消化病与影像杂志：电子版，2016，6（3）：97-102.DOI：10.3877/cma.j.issn.2095-2015.2016.03.001.
JIN P,SUN G.Research progress of local ablation therapy for hepatocellular carcinoma［J］.Chin J Digest Med Imageol (Electronic Edition),2016,6(3):97-102.DOI：10.3877/cma.j.issn.2095-2015.2016.03.001.

相似文献/References:

[1]王克霞,张荣波,唐小龙,等.肝细胞性肝癌与乙型肝炎病毒感染相关性的研究[J].新乡医学院学报,1997,14(03):281.
[2]杨瑞民,张凯,李玉侠,等.巨块型肝癌肝动脉栓塞后无水酒精注射疗效观察[J].新乡医学院学报,1997,14(04):382.
[3]甄艳华,杨利霞.肝癌患者肝动脉血流动力学的彩色多普勒研究[J].新乡医学院学报,2008,25(01):062.
[4]沈洁,阮健,郑航,等.ZD6474对肝癌HepG2细胞的抑制作用[J].新乡医学院学报,2010,27(03):234.
[5]黄长山,余伟,王云检,等.外科Apgar评分在肝癌术后并发症预测中的应用 TitleFilter('chTitle');[J].新乡医学院学报,2010,27(04):365.
[6]孙春伟,吴广银.哺乳动物雷帕霉素靶蛋白对肝癌细胞系Hep3B中侧群细胞的影响[J].新乡医学院学报,2011,28(03):307.
[7]王　雷１,王煜霞２,薛会朝１. 肝癌患者肿瘤坏死因子α和白细胞介素８水平变化及其与临床病理特征的关系[J].新乡医学院学报,2015,32(08):735.
[8]罗羽田,李世朋,徐红伟,等.铁死亡在肝癌中的调控机制及作用研究进展[J].新乡医学院学报,2021,38(1):091.[doi:10.7683/xxyxyxb.2021.01.020]
[9]王政强,韩锋博.肝癌切除术联合肝动脉化疗栓塞术治疗中晚期肝癌疗效观察[J].新乡医学院学报,2021,38(10):957.[doi:10.7683/xxyxyxb.2021.10.012]
　WANG Zhengqiang,HAN Fengbo.Effect of hepatectomy combined with transcatheter hepatic arterial chemoembolization in the treatment of middle-advanced liver cancer[J].Journal of Xinxiang Medical University,2021,38(4):957.[doi:10.7683/xxyxyxb.2021.10.012]
[10]李　妍,朱绍辉,张　彬.肝癌患者肝切除术后感染性并发症的相关危险因素分析[J].新乡医学院学报,2016,33(9):767.[doi:10.7683/xxyxyxb.2016.09.007]
　LI Yan,ZHU Shao-hui,ZHANG Bin.Analysis of the risk factors for infectious complications in patients with hepatocellular carcinoma after hepatectomy[J].Journal of Xinxiang Medical University,2016,33(4):767.[doi:10.7683/xxyxyxb.2016.09.007]

更新日期/Last Update: 2022-04-05